TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
EBS

Emergent Biosolutions Inc

Healthcare · Drug Manufacturers - Specialty & Generic

6.60$ -3.7% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Emergent Biosolutions Inc (EBS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,117 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet EBS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,893 1,835 1,804 1,514 1,478 1,397 1,426 1,417 1,461 1,319 1,320 1,117
711 680 682 655 661 599 707 720 787 663 638 666
88 112 79 70 150 106 149 271 246 205 160 140
88 112 79 70 150 106 149 271 246 205 160 140
217 191 234 196 121 155 204 80 150 84 122 190
354 329 333 318 323 312 314 339 356 343 328 304
413 – – – 291 282 228 224 217 216 – –
218 0.0 – – 0.0 – – – – – – –
583 567 550 534 518 502 485 469 453 437 470 262
1,196 1,186 1,140 1,127 969 914 873 881 879 796 797 775
664 651 630 620 230 162 112 127 137 132 149 123
417 417 463 418 3.5 2.7 0.0 1.8 0.0 0.0 – –
113 112 100 96 82 61 58 64 57 56 40 50
448 447 447 447 662 664 666 668 663 572 574 582
697 649 664 386 508 483 553 536 583 523 523 341
28 -22 -13 -296 -181 -212 -144 -156 -105 -160 -153 -333
52 52 52 53 56 54 57 54 57 52 57 52

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?